missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Recombinant Human UBE2R1/CDC34 Protein

Product Code. 18604337 Shop All Bio Techne Products
Click to view available options
Quantity:
100 μg
1000 μg
5 μg
500 μg
Unit Size:
1000µg
100µg
500µg
5µg
This item is not returnable. View return policy

Product Code. 18604337

Brand: Novus Biologicals™ NBP261361100ug

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Recombinant Protein

Data is not available.
TRUSTED_SUSTAINABILITY

Specifications

For Use With (Application) SDS-PAGE
Formulation A 0.2 μm filtered concentrated solution in 50 mM HEPES, pH 7.0, 125 mM NaCl, 10 % Glycerol, 1 mM DTT.
Gene ID (Entrez) 997
Molecular Weight (g/mol) MolecularWeight-theroretical: 26.7 kDa
Quantity 100 μg
Storage Requirements Store at -20°C. Avoid freeze/thaw cycles.
Endotoxin Concentration Less than 0.1 EU/μg of UBE2R1/CDC34 as determined by LAL method.
Gene Alias cell division cycle 34, cell division cycle 34 homolog (S. cerevisiae), E2-CDC34, EC 6.3.2.19, UBC3, UBE2R1UBCH3, ubiquitin carrier protein, ubiquitin-conjugating enzyme E2 R1, Ubiquitin-conjugating enzyme E2-32 kDa complementing, Ubiquitin-conjugating enzyme E2-CDC34, Ubiquitin-protein ligase R1
Gene Symbol CDC34
Research Category Cancer, Cell Cycle and Replication, Core ESC Like Genes, Stem Cell Markers
Purity or Quality Grade >95%, by SDS-PAGE and HPLC
Protein UBE2R1/CDC34
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.